Centre for Research In Molecular Medicine

Institute of Molecular Biology and Biotechnology

INTRODUCTION

During the last three decades, the discipline of molecular and cellular biology has expanded phenomenally in scope and in-depth. New knowledge in the field, mainly acquired through a multidisciplinary approach and experimental research, has made it possible not only to unravel living processes in health and disease from molecular to organismal level but also to introduce novel and more effective therapeutic and diagnostic tools in medical practice.

In line with the policy of the University of Lahore to develop high-quality expertise and manpower in emerging areas of biomedical sciences, the IMBB incorporates and developed a Centre for Research in Molecular Medicine that was initiated in April 2009. The Centre represents a major investment and a bold initiative by the University in the field of life sciences and human health. A covered area of approximately 9,000 sq feet was allocated to the Centre at the University’s new campus adjacent to the University College of Medicine, to develop purpose-built teaching and research laboratories with state-of-the-art facilities. The Centre draws resources from other academic units of the University as well, such as the Institute of Molecular Biology and Biotechnology, Department of Pharmacy, the University College of Medicine, and the Department of Information Technology.

The Centre also has close collaboration in relevant areas with other reputable institutions within and outside the country. The Centre aims at conducting high-quality research and postgraduate training in biomedical sciences with strong relevance to current issues of human health in the local and regional context. The Centre has a strong integrative and multidisciplinary approach to carry out basic and clinically oriented research and postgraduate training on specific problems ranging from molecular to epidemiological levels. To accomplish these goals the CRiMM strives to bring together young scientists and physicians under a common roof to interact and resolve problems related to health and disease with a holistic approach.

OBJECTIVES

  • To conduct quality research in molecular medicine and related disciplines with strong relevance to human health in the local context.
  • To provide research training of postgraduate students in biomedical sciences, leading to PhD
  • To firm up research linkages and interactive cooperation with national and international institutions conducting similar
  • To attract scientists and physicians for short term training in molecular medicine techniques and invite foreign and local experts for lectures and in research advisory
  • To publish scientific articles based on research conducted at the Centre in peer-reviewed international
  • To generate high-quality manpower to meet the demand for qualified faculty and scientists, in institutions both educational and research, and in
  • To provide an open, stimulating, and nurturing environment for training and career development in biomedical

MISSION STATEMENT

  • Foster professional and intellectual development of scholars and faculty members at all levels. Place major emphasis on quality of the postgraduate programme leading to
  • Undertake basic research in areas of national importance in the sectors of biomedical sciences and
  • Actively interact and collaborate in research and higher training with other relevant institutions within and outside the
  • Promote research interaction with public agencies and industry through outreach and scientific
  • Organize symposia, seminars and special lectures in relevant disciplines at national and international

Accreditation

Accredited with (HEC) Higher Education Commission of Pakistan. HEC awarded W4 Category to UOL in 2012.
CURRENT RESEARCH AREAS IN CRIMM
  • Genetics and molecular biology of cancer and associated disease
  • Genetics and biochemistry of metabolic diseases with special emphasis on obesity and diabetes
  • Recombinant DNA techniques
  • Cell signaling mechanisms using cancer and endocrine cells as models
  • Undertake the production of monoclonal and polyclonal antibodies used in medical diagnostics and applied medical research
  • Cell and tissue culture technology
  • Stem cell technology
  • Genetics and biology of idiopathic infertility

ADVISORY COMMITTEE

E. NIESCHLAG, PHD, FRCP
Professor
University of Muenster Muenster, Germany

MASOOD SHAMS, PHD
Professor
Harvard University, Harvard, MA, USA

SCHLATT, PHD
Professor and Director CeRA
University of Muenster Muenster, Germany

T.A. BUTT, FRCP
Professor
Fatima Memorial Medical College Lahore, Pakistan

JAIDA MANZOOR, FCPS
Associate Professor
Children’s Hospital Lahore, Pakistan

AKHTAR, PHD, FPAS, SI
University of the Punjab Lahore, Pakistan

SAEED, PHD
Research Scientist
CNRS, University of Lille Lille, France